Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction

Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction

Background: There is ongoing debate regarding the optimal antiplatelet strategy beyond 12 months in patients with acute myocardial infarction (AMI) who undergo successful percutaneous coronary intervention (PCI). This study therefore aimed to investigate the clinical outcomes of single (SAPT) vs. du...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ji Woong Roh, SungA Bae, Yongcheol Kim, Nak-Hoon Son, Deok-Kyu Cho, Jung-Sun Kim, Byeong-Keuk Kim, Donghoon Choi, Myeong-Ki Hong, Myung Ho Jeong, Yangsoo Jang, the KAMIR-NIH Investigators
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
acute myocardial infarction
antiplatelet therapy
aspirin
clopidogrel
major adverse cardiac and cerebral event
Diseases of the circulatory (Cardiovascular) system
RC666-701
Acceso en línea:https://doaj.org/article/9b981fb1b590491c8d5af377adadd2e1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/9b981fb1b590491c8d5af377adadd2e1

Ejemplares similares